---
category: news
title: "Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights"
excerpt: "Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR Â® artificial intelligence (\"A.I.\") and machine learning (\"M.L.\") platform to transform the cost,"
publishedDateTime: 2022-11-07T21:18:00Z
originalUrl: "https://technews.tmcnet.com/news/2022/11/07/9707792.htm"
webUrl: "https://technews.tmcnet.com/news/2022/11/07/9707792.htm"
type: article

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "rczVIxbcQkPuDzRBaVesVymMTpAioELSnrlW2kgpMuj82AwqYrd+xHqHV4baGtyOYQd2koEbrPrecZ3d3Hg1itNA7JHGRhJHO3Jpna9wcHobpU0ZL/pCHtRILV91Q1QU1RV6OW6iXfcuQo4OBEU9NA10xyJExu1ZBN4/VTQ5bwPPqGbYgw8u7XbdfXYcdQwfe1my++PaxwjetpdbIxLZE/4OVUHA/HYIZhw63xGZ4f2QUct42a0BjK1euWPREFBW2053F77oSsjZZO+HZuh2eKx0HZHMCTUPyDK7wxdiizxD8JXbT1Nn+Kski/zn/DbN5+IqEkfVApyTH2kZKz6/rpdPpYk6/eaIGYyveFHXzJQ=;16HkSKfygmdymPVs4xhs7g=="
---

